Snippet from the article:
Just seven months after its $5.5 million Series A financing round, the Boston-based startup today announced it has raised an additional $11 million to bolster its efforts to develop new methods of treating male- and female-pattern baldness and other hair-follicle disorders such as excessive hair growth and acne.
Read the full story — New Fundraising for Hair-Raising: Follica Takes in $11 Million for Baldness-Treatment Approach
What does this all mean for the future of hair cloning / multiplication? Well, that remains to be seen. This is exciting stuff and I hope the additional funds will bring this technology to the next level. As for when/if it’ll make it to market — well, I couldn’t say. Follica just came on the scene in late 2006 and I’d expect many years to come before anything of substance came out, if at all. Not to be a pessimist, but we’ve seen a number of failed attempts at these types of methods over the years. Lots of questions remain, and this is still the very, very early stages.
Actually, Follica isn’t hair follicular cloning. It was based on an accidental discovery that wnt’s injected into a surface wound causes the appearance of new hair follicles.